BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35294759)

  • 1. Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation.
    Nguyen HN
    Methods Mol Biol; 2022; 2474():93-105. PubMed ID: 35294759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Standardized and Reproducible Forebrain-type Cerebral Organoids from Human Induced Pluripotent Stem Cells.
    Krefft O; Jabali A; Iefremova V; Koch P; Ladewig J
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Culture of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoid Cells.
    Yan Y; Arzua T; Logan S; Bai X
    Methods Mol Biol; 2022; 2454():483-494. PubMed ID: 33029748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human brain region-specific organoids using a miniaturized spinning bioreactor.
    Qian X; Jacob F; Song MM; Nguyen HN; Song H; Ming GL
    Nat Protoc; 2018 Mar; 13(3):565-580. PubMed ID: 29470464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically Amendable, Defined, and Rapid Induction of Human Brain Organoids from Induced Pluripotent Stem Cells.
    Tomaskovic-Crook E; Crook JM
    Methods Mol Biol; 2019; 1576():13-22. PubMed ID: 29119484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models.
    Kiaee K; Jodat YA; Bassous NJ; Matharu N; Shin SR
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In depth characterization of midbrain organoids derived from wild type iPSC lines.
    Pavlinov I; Tambe M; Abbott J; Nguyen HN; Xu M; Pradhan M; Farkhondeh A; Zheng W
    PLoS One; 2023; 18(10):e0292926. PubMed ID: 37862312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of 3D-Multicellular Human iPSC-Heart Organoids for the Noninvasive Assessment of Cardiac Fibrosis.
    Lucena-Cacace A; Tian Y; Yoshida Y
    Methods Mol Biol; 2024; 2803():35-48. PubMed ID: 38676883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research.
    Nguyen R; Da Won Bae S; Qiao L; George J
    Cancer Lett; 2021 Jun; 508():13-17. PubMed ID: 33771683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
    Nam KH; Yi SA; Jang HJ; Han JW; Lee J
    Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniform cerebral organoid culture on a pillar plate by simple and reproducible spheroid transfer from an ultralow attachment well plate.
    Acharya P; Joshi P; Shrestha S; Choi NY; Jeong S; Lee MY
    Biofabrication; 2024 Jan; 16(2):. PubMed ID: 38176079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology.
    Raggi C; Selleri S; M'Callum MA; Paganelli M
    Curr Protoc; 2022 Mar; 2(3):e389. PubMed ID: 35263041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.